For the best experience on the Abcam website please upgrade to a modern browser such as Google Chrome
We use cookies to make our site as useful as possible.
Our Cookie Policy explains how you can opt-out of the cookies we use.
If you continue without changing your cookie settings, we'll assume you’re happy with this.
Cancer resistance to chemotherapy is a major barrier to successful treatment. Resistance is often caused by proteins such as multidrug resistance-associated proteins (MRPs) and P glycoproteins that pump chemotherapy agents from cells, but also occurs due to secondary mutations in drug targets or effectors. Use this page to find out more.
Dr George Prendergast discusses the future of immunochemotherapy.
Discover over 70 of our scientific posters covering all research areas.
637497563610000000
Protocol